Cannabis – The ANMAT approved a procedure to authorize cannabis-based medicinal products
By Belen Recchini and Antonella Balbo. On August 16, 2022, the National Administration of Medicines, Food, and Technology (ANMAT, for its acronym in Spanish), approved through Provision No. 6431/2022, the “Guide for the sanitary authorization of cannabis-based plant products and their by-products intended for use and application in human medicine” (Guide), in line with Resolution […]
read more